MCAT and breast carcinoma: In our earlier studies, performed on a group of 60 patients with ductal breast cancer, postoperatively treated with tamoxifen, expression of metallothionein (MT), which is downregulated by ER was found to be an unfavourable prognostic factor (Surowiak et al, 2005b).